Unlock instant, AI-driven research and patent intelligence for your innovation.

Guanylate-binding protein

a technology of guanylate and binding protein, which is applied in the field of guanylate binding protein, can solve the problems that stomach cancer is a leading cause of cancer deaths worldwid

Inactive Publication Date: 2006-12-07
PENNICA DIANE
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

GBP-4 provides a molecular target for therapeutic intervention in gastric cancer, potentially inhibiting cancer cell proliferation and offering a tool for diagnosing and treating gastric adenocarcinoma with reduced impact on normal tissues.

Problems solved by technology

Cancer of the stomach is a leading cause of cancer deaths worldwide.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Guanylate-binding protein
  • Guanylate-binding protein
  • Guanylate-binding protein

Examples

Experimental program
Comparison scheme
Effect test

examples

[0205] Commercially available reagents referred to in the examples were used according to manufacturer's instructions unless otherwise indicated. The source of those cells identified in the following examples, and throughout the specification, by ATCC accession numbers is the American Type Culture Collection, Rockville, Md.

example i

Cloning of Human GBP-4

1. Materials and Methods

Cells and Reagents

[0206] The following cell lines were obtained from the American Type Culture Collection (Rockville, Md.) and grown as recommended: 293, human embryonic kidney cells, HeLa, human epitheloid carcinoma of the cervix (ATCC, CCL-2), A431, human epidermoid carcinoma (ATCC, CRL-1555), RF-1, derived from a human primary gastric adenocarcinoma (ATCC, CRL-1864), RF-48, derived from a human gastric adenocarcinoma metastatic to peritoneal fluid (ATCC, CRL-1863), AGS, derived from a human primary gastric adenocarcinoma (ATCC, CRL-1739), KATO III, a human gastric carcinoma metastatic to pleural fluid (ATCC, HTB-103), and Hs746T, derived from a human stomach carcinoma metastatic to the left leg (ATCC, HBT-135). Purified recombinant human IFN-γ was obtained from Genentech, Inc. The rHuIFN-γ and rHuIFN-α used in this example displayed specific anti-viral activities of 2×107 and 5×106 IU / mg, respectively (1.0 IU of IFN-α per ml=30 f...

example ii

E. coli Expression of cDNA Encoding Human GBP-4

[0253] An expression vector from Qiagen Inc. called pQE-30 was used for this example. A restriction map of pQE-30 is shown in FIG. 8. The plasmid for GBP-4 of Example I was digested with BamHI and SalI. The resulting DNA fragment was ligated into pQE-30 previously cut with BamHI and SalI to accommodate the DNA fragment using standard ligation methodology as described in Sections 5.10 to 5.11 of Sambrook et al., supra. The resulting vector is called pQE30.hu.GBP4.

[0254] Competent E. coli 27C7 cells were transformed with pQE30.hu.GBP4 by standard transformation techniques. Transformants were selected and purified on LB plates containing 20 mg / L tetracycline. This medium had the following composition: 10 g / L Bacto-Tryptone, 5 g / L yeast extract, 10 g / L sodium chloride, and 20 mg / L tetracycline-HCl.

[0255] One transformed colony was used to inoculate sterile LB broth containing 20 mg / L tetracycline. The flask culture was incubated at 35-39...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
pHaaaaaaaaaa
temperatureaaaaaaaaaa
pHaaaaaaaaaa
Login to View More

Abstract

A member of the guanylate-binding protein family, designated GBP-4, is provided. Also provided are isolated nucleic acid encoding GBP-4, vectors and host cells containing such nucleic acid molecule, and a method for producing the GBP-4 recombinantly.

Description

[0001] This invention was made with government support under grant R29DK48748 awarded by the National Institutes of Health. The government has certain rights in the invention.BACKGROUND OF THE INVENTION [0002] 1. Field of the Invention [0003] This invention relates to a member of the guanylate-binding protein family designated as GBP-4 and the cloning and expression of nucleic acid encoding this protein. The invention further relates to methods of production of the isolated molecule and its uses. [0004] 2. Description of Related Disclosures [0005] One approach to understanding the molecular basis of cancer is to identify differences in gene expression between cancer cells and normal cells. Strategies based on assumptions that steady-state mRNA levels will differ between normal and malignant cells have been used to clone differentially expressed genes. Zhang et al., Science, 276: 1268-1272 (1997). The recent development and successful application of such strategies include the use of...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): C12Q1/68C07H21/04C12P21/06C12P19/34C12N9/22C07K14/47H05K7/14H05K7/20
CPCC07K14/47Y10S977/924Y10S977/775
Inventor PENNICA, DIANE
Owner PENNICA DIANE